T-lymphocytes in B-cell chronic lymphocytic leukaemia.

R. Foà,D. Catovsky,F. Lauria,M. N. Zafar,D. Galton

Haematologica

Abstract:

What problem does this paper attempt to address?

The burden of iodine deficiency

Zhifei Wu,Yu Liu,Wenjuan Wang

DOI: https://doi.org/10.5114/aoms/178012

2024-02-22

Archives of Medical Science

Abstract:Introduction Iodine deficiency is a global issue; however, no comparable assessments of the burden of iodine deficiency have been conducted worldwide. Hence, we measured the estimated annual percentage changes (EAPCs) from 1990 to 2019. Our aim was to quantify the geographic differences in the burden of iodine deficiency worldwide. Material and methods The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 methodology was employed to investigate the worldwide, regional, and national incidence of iodine deficiency and the accompanying disability-adjusted life years (DALYs). Results The global age-standardized incidence (ASI) and DALY rates of iodine deficiency declined from 1990 to 2019, with an EAPC of –0.44 and –1.35, respectively. Low and low-middle SDI had much higher ASI and DALY rates of iodine deficiency than other SDI regions. At the regional level, the largest growth in the ASI rate of iodine insufficiency from 1990 to 2019 occurred in East Asia, and at the national level, the greatest increases in the ASI rate of iodine deficiency occurred in the Philippines, Pakistan and Nepal. In addition, males had a lower worldwide ASI rate of iodine insufficiency than females did, with the incidence rate peaking in populations aged 20–24. Conclusions Between 1990 and 2019, there was a decline in the global ASI and DALY rates of iodine deficiency. However, East Asia, the Philippines, Pakistan and Nepal exhibited the largest increases in the ASI rates of iodine deficiency, demonstrating their significant burden of iodine insufficiency. These regions must therefore be targeted for intervention.

medicine, general & internal
Changing trends in the global, regional, and national burden of iodine deficiency among adolescents and young adults: population-based study

Boshen Gong,Chuyuan Wang,Wanyu Yang,Zhongyan Shan

DOI: https://doi.org/10.1007/s00431-024-05545-z

2024-04-10

European Journal of Pediatrics

Abstract:Iodine is a micronutrient required for the production of thyroid hormones, which regulate metabolism, growth, and neurodevelopment. Iodine deficiency among adolescents and young adults is a major global health issue. We analyzed data from the Global Burden of Disease 2019 database to calculate the prevalence, incidence, and disability-adjusted life-year (DALY) rates of iodine deficiency among adolescents and young adults. We explored the specific year with the most substantial changes in the trends of iodine deficiency among adolescents with annual percentage change (APC) by Joinpoint Regression analysis. Descriptive analyses were conducted to characterize the iodine deficiency burden according to age, sex, location, and sociodemographic index (SDI) quintiles. All measures are listed with 95% uncertainty intervals (UIs), and all rates are reported per 100,000 individuals. From 1990 to 2019, the iodine deficiency prevalence rate among adolescents decreased from 3082.43 (95% uncertainty interval [UI], 2473.01–3855.86) to 2190.84 (95% [UI], 1729.18–2776.16) per 100,000 population, with an AAPC of -1.15 (95% confidence interval [CI], -1.29 to -1.02). Regarding the SDI in 2019, the highest prevalence and DALY rates of iodine deficiency were reported in low-SDI countries. In 1990, Southeast Asia had the highest prevalence and DALYs rates for iodine deficiency among adolescents, while in 2019, Africa had the highest prevalence rate (3330.12).

pediatrics
Burden and trends of iodine deficiency in Asia from 1990 to 2019

R Wei,Z Wang,X Zhang,X Wang,Y Xu,Q Li

DOI: https://doi.org/10.1016/j.puhe.2023.06.034

IF: 4.984

Public Health

Abstract:Objectives: Understanding iodine deficiency (ID) burdens and trends in Asia can help guide effective intervention strategies. This study aims to report the incidence, prevalence, and disability-adjusted life years (DALYs) of ID in 48 Asian countries during the period 1990-2019. Study design: Data on ID were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 and estimated by age, sex, geographical region, and sociodemographic index (SDI). Methods: The estimated annual percentage change (EAPC) was calculated to evaluate the changing trend of age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized DALYs rate (ASDR) related to ID during the period 1990-2019. Results: In Asia, there were 126,983,965.8 cases with 5,466,213.1 new incidence and 1,765,995.5 DALYs of ID in 2019. Between 1999 and 2019, the EAPC in ASIR, ASPR and ASDR were -0.6 (95% confidence interval [CI], -0.8 to -0.4), -0.9 (95% CI, -1.2 to -0.7), and -1.6 (95% CI, -1.8 to -1.5), respectively. Malaysia charted the largest decrease in ASIR, ASPR, and ASDR (82.4%, 85.3%, and 80.9% separately), whereas the Philippines and Pakistan were the only two countries that witnessed an increase in ASIR and ASPR. ID burdens were more pronounced in women, countries located to the south of the Himalayas, and low-middle SDI regions. Conclusions: The incidence, prevalence, and DALYs of ID in Asia substantially decreased from 1990 to 2019. Women and low-middle SDI countries have relatively high ID burdens. Governments need to pay constant attention to the implementation and monitoring of universal salt iodization.
Cross-country health inequalities of four common nutritional deficiencies among children, 1990 to 2019: data from the Global Burden of Disease Study 2019

Wenkai Jiang,Xiao Li,Ruiying Wang,Yan Du,Wence Zhou

DOI: https://doi.org/10.1186/s12889-024-17942-y

IF: 4.5

2024-02-15

BMC Public Health

Abstract:Abstract Background Nutritional deficiencies remain serious medical and public health issues worldwide, especially in children. This study aims to analyze cross-country inequality in four common nutritional deficiencies (protein-energy malnutrition, dietary iron deficiency, vitamin A deficiency and iodine deficiency) among children from 1990 to 2019 based on Global Burden of Disease (GBD) 2019 data. Methods Prevalence and disability-adjusted life years (DALYs) data as measures of four nutritional deficiency burdens in people aged 0 to 14 years were extracted from the GBD Results Tool. We analyzed temporal trends in prevalence by calculating the average annual percent change (AAPC) and quantified cross-country inequalities in disease burden using the slope index. Results Globally, the age-standardized prevalence rates of dietary iron deficiency, vitamin A deficiency and iodine deficiency decreased, with AAPCs of -0.14 (-0.15 to -0.12), -2.77 (-2.96 to -2.58), and -2.17 (-2.3 to -2.03) from 1999 to 2019, respectively. Significant reductions in socio-demographic index (SDI)-related inequality occurred in protein-energy malnutrition and vitamin A deficiency, while the health inequality for dietary iron deficiency and iodine deficiency remained basically unchanged. The age-standardized prevalence and DALY rates of the four nutritional deficiencies decreased as the SDI and healthcare access and quality index increased. Conclusions The global burden of nutritional deficiency has decreased since 1990, but cross-country health inequalities still exist. More efficient public health measures are needed to reduce disease burdens, particularly in low-SDI countries/territories.

public, environmental & occupational health
Iron Deficiency: Global Trends and Projections from 1990 to 2050

Li Wang,Dan Liang,Hengqian Huangfu,Xinfu Shi,Shuang Liu,Panpan Zhong,Zhen Luo,Changwen Ke,Yingsi Lai

DOI: https://doi.org/10.3390/nu16203434

IF: 5.9

2024-10-11

Nutrients

Abstract:Background: Iron deficiency (ID) remains the leading cause of anemia, affects a vast number of persons globally, and continues to be a significant global health burden. Comprehending the patterns of ID burden is essential for developing targeted public health policies. Methods: Using data from the Global Burden of Disease (GBD) 2021 study for the years 1990–2021, the XGBoost model was constructed to predict prevalence and disability-adjusted life years (DALYs) for the period 2022–2050, based on key demographic variables. Shapley Additive exPlanations (SHAP) values were applied to interpret the contributions of each variable to the model's predictions. Additionally, the Age–Period–Cohort (APC) model was used to evaluate the effects of age, period, and birth cohort on both prevalence and DALYs. The relationship between the Socio-Demographic Index (SDI) and ID's age-standardized prevalence rate (ASPR) as well as the age-standardized DALYs rate (ASDR) was also analyzed to assess the influence of socioeconomic development on disease burden. Results: The global prevalent cases of ID grew from 984.61 million in 1990 to 1270.64 million in 2021 and are projected to reach 1439.99 million by 2050. Similarly, global DALYs from ID increased from 28.41 million in 1990 to 32.32 million in 2021, with a projected rise to 36.13 million by 2050. The ASPR declined from 18,204/100,000 in 1990 to 16,433/100,000 in 2021, with an estimated annual percentage change (EAPC) of −0.36% over this period. It is expected to decrease further to 15,922 by 2050, with an EAPC of −0.09% between 2021 and 2050. The ASDR was 518/100,000 in 1990 and 424/100,000 in 2021, with an EAPC of −0.68% from 1990 to 2021. It is expected to remain relatively stable at 419/100,000 by 2050, with an EAPC of −0.02% between 2021 and 2050. In 2021, the highest ASPRs were recorded in Senegal (34,421/100,000), Mali (34,233/100,000), and Pakistan (33,942/100,000). By 2050, Mali (35,070/100,000), Senegal (34,132/100,000), and Zambia (33,149/100,000) are projected to lead. For ASDR, Yemen (1405/100,000), Mozambique (1149/100,000), and Mali (1093/100,000) had the highest rates in 2021. By 2050, Yemen (1388/100,000), Mali (1181/100,000), and Mozambique (1177/100,000) are expected to remain the highest. SHAP values demonstrated that gender was the leading predictor of ID, with age and year showing negative contributions. Females aged 10 to 60 consistently showed higher prevalence and DALYs rates compared to males, with the under-5 age group having the highest rates for both. Additionally, men aged 80 and above exhibited a rapid increase in prevalence. Furthermore, the ASPR and ASDR were significantly higher in regions with a lower SDI, highlighting the greater burden of ID in less developed regions. Conclusions: ID remains a significant global health concern, with its burden projected to persist through 2050, particularly in lower-SDI regions. Despite declines in ASPR and ASDR, total cases and DALYs are expected to rise. SHAP analysis revealed that gender had the greatest influence on the model's predictions, while both age and year showed overall negative contributions to ID risk. Children under 5, women under 60, and elderly men aged 80+ were the most vulnerable groups. These findings underscore the need for targeted interventions, such as improved nutrition, early screening, and addressing socioeconomic drivers through iron supplementation programs in low-SDI regions.

nutrition & dietetics
WITHDRAWN: Cardio-cerebrovascular protective effects of valsartan in high-risk hypertensive patients with overweight/obesity: A post-hoc analysis of the KYOTO HEART Study.

Hidekazu Irie,J. Shiraishi,T. Sawada,Masahiro Koide,H. Yamada,H. Matsubara

DOI: https://doi.org/10.1016/j.ijcard.2012.06.103

IF: 4.039

2012-07-12

International Journal of Cardiology

Abstract:
[Trends of the Disease Burden of Intellectual Disability among Children and Adolescents from 1990 to 2019 in China].

X J Yan,S Q Lin,J,L J Pei

DOI: https://doi.org/10.3760/cma.j.cn112338-20220303-00165

2022-01-01

Abstract:Objective: This study aims to analyze the disease burden of intellectual disability among Chinese children and adolescents aged 0-19 years in 2019 and its trends from 1990 to 2019. Methods: Data were gathered from the Global Burden of Disease study. The prevalence and years lived with disability (YLDs) of intellectual disability among Chinese children and adolescents were compared with the global average by gender, age group, and severity of disability in 2019. Joinpoint regression model was used to analyze the trends in the prevalence and YLDs of intellectual disability among Chinese children and adolescents from 1990 to 2019. Results: The prevalence and YLDs of intellectual disability among Chinese children and adolescents in 2019 were 1 522.65 per 100 000 (95%UI: 1 228.62 per 100 000-1 817.55 per 100 000) and 109.81 per 100 000 (95%UI: 72.15 per 100 000-158.09 per 100 000), respectively, which were lower than the global average. The prevalence and YLDs of severe intellectual disability in China were slightly higher than the global average. The average annual percent changes in the prevalence and YLDs of intellectual disability among Chinese children and adolescents were -0.23% (95%CI: -0.26%--0.21%, P<0.001) and 0.74% (95%CI: 0.66%-0.81%, P<0.001) from 1990 to 2019, respectively. The prevalence and YLDs of severe intellectual disability showed continuously increasing trends over the past 30 years. Conclusions: The disease burden of intellectual disability among Chinese children and adolescents was lower than the global average in 2019, but severe intellectual disability was higher than the global average. The prevalence of intellectual disability among Chinese children and adolescents showed an overall decrease, while YLDs showed an increasing trend from 1990 to 2019.
Global Patterns in Vision Loss Burden Due to Vitamin A Deficiency from 1990 to 2017.

Yufeng Xu,Yi Shan,Xiling Lin,Qi Miao,Lixia Lou,Yijie Wang,Juan Ye

DOI: https://doi.org/10.1017/s1368980021001324

2021-01-01

Public Health Nutrition

Abstract:Objective: To investigate the vision loss burden due to vitamin A deficiency (VAD) at the global, regional and national levels by year, age, sex and socio-economic status using prevalence and years lived with disability (YLD). Design: International, retrospective, comparative burden-of-disease study. Setting: Prevalence and YLD data were extracted from the Global Burden of Disease (GBD) Study 2017. The association of age-standardised YLD rates and human development index (HDI) was tested by Pearson correlation and linear regression analyses. The Gini coefficient and concentration index (CI) were calculated to demonstrate the trends in between-country inequality in vision loss burden due to VAD. Participants: All participants met the GBD inclusion criteria. Results: The age-standardised prevalence rate increased by 9 center dot 2 %, while the age-standardised YLD rates rose by 10 center dot 8 % from 1990 to 2017. Notably, the vision loss burden caused by VAD showed a declining trend since 2014. The vision loss burden was more concentrated in the post-neonatal age group and decreased with increasing age. The age-standardised YLD rates were inversely correlated with HDI (r = -0 center dot 2417, P = 0 center dot 0084). The CI and Gini coefficients indicated that socio-economic-related and between-country inequality declined from 2000 to 2017. VAD was the eighth leading cause of the age-standardised prevalence rate and ninth leading cause of age-standardised YLD rate among fifteen causes of vision loss in 2017. Conclusion: VAD has become one of the significant leading causes of vision loss globally. Efforts to control vision impairment related to VAD are needed, especially for children in countries with lower socio-economic status.
Iodine Deficiency in Zhejiang Pregnant Women in the Context of Universal Salt Iodization Programme

Zhifang Wang,Mingluan Xing,Wenming Zhu,Guangming Mao,Zhe Mo,Yuanyang Wang,Zhijian Chen,Xiaoming Lou,Shichang Xia,Xiaofeng Wang

DOI: https://doi.org/10.1038/s41598-018-26942-z

IF: 4.6

2018-01-01

Scientific Reports

Abstract:Zhejiang introduced universal salt iodization (USI) programme in 1995 and has achieved the goal of elimination of iodine deficiency disorders (IDD) since 2011. However, no systematical data of iodine nutritional status in population in pregnancy is available. In this cross-sectional study, pregnant women were interviewed to complete questionnaires in addition to handing in samples of urine and household table salt between March 2016 to February 2017. Date of birth, age of pregnancy, ethnicity and dietary iodine habits were recorded. The overall median urinary iodine concentration in 8561 pregnant women was 130.47 µg/L, which was lower than the cut-off value of iodine sufficiency of 150 µg/L recommended by the WHO. Participants using non-iodized salt, taking non-iodine-containing supplements, in coastal and in Han group were independently associated with iodine deficiency. The current USI programme did not supply Zhejiang pregnant women with sufficient iodine intake. They are generally iodine deficient, which have great public health importance since even mild IDD in pregnancy have adverse effects on fetal neurodevelopment. We strongly recommend urgent measures to improve iodine intake in pregnancy.
Global, regional, and national burdens of nutritional deficiencies, from 1990 to 2019

Xin Qing,Yurou Ji,Chunlei Yuan,Kunke Xie,Ke Wang

DOI: https://doi.org/10.1017/s0007114524001272

2024-06-05

British Journal Of Nutrition

Abstract:The epidemiological and burden characteristics of nutritional deficiencies (NDs) have been evolving, and it is crucial to identify geographical disparities and emerging trends. This study aimed to analyze the global, regional, and national trends in the burden of NDs over the past 30 years. Data were obtained from the Global Burden of Disease (GBD) 2019 database for the period 1990-2019. The study examined the incidence rates and disability-adjusted life years (DALYs) of NDs at various levels. Globally, the incidence rate of NDs decreased from 2226.2 per 100,000 in 2019 to 2096.3 per 100,000 in the same year, indicating a decline of 5.8%. The average annual percentage change (AAPC) was -0.21 (-0.31 to -0.11). Similarly, DALYs, prevalence, and mortality rates of NDs exhibited significant declines (AAPC = -3.21 [-3.45 to -2.96], AAPC = -0.53 [-0.55 to -0.51], and AAPC = -4.97 [-5.75 to -4.19], respectively). The incidence rate of NDs varied based on age group, gender, cause, and geographical area. Moreover, a negative association was observed between incidence and the sociodemographic index. At the regional level, the South Asia and Sub-Saharan Africa regions had the highest incidence rates of NDs. In conclusion, the global incidence rate of NDs showed a mixed pattern, while the DALY rate consistently declined. Additionally, prevalence and mortality rates of NDs decreased between 1990 and 2019.

nutrition & dietetics
Global burden and inequality of iron deficiency: findings from the Global Burden of Disease datasets 1990-2017

Mengying Wang,He Gao,Jianing Wang,Chenliang Cao,Xiaoling Ying,Yingming Wei,Zhiying Yu,Jie Shao,Hengjin Dong,Min Yang

DOI: https://doi.org/10.1186/s12937-022-00771-3

2022-03-18

Abstract:Background: Iron deficiency (ID) impairs patient physical activity, recognition and life quality, which is difficult to perceive but should not be underestimated. Worldwide efforts have been made to lower ID burden, however, whether it decreased equally in different regions and sexes is unclear. This study is to examine regional and sex inequalities in global ID from 1990 to 2017. Methods: We conducted a longitudinal, comparative burden-of-disease study. Disability-adjusted life-years (DALYs) of ID were obtained from Global Burden of Disease Report 2017. Human Development Index (HDI) data were obtained from Human Development Report 2017. Gini coefficient and the concentration index were calculated to assess the equities in global burden of ID. Results: A downward trend of global ID burden (from 569.3 (95% Uncertainty Interval [UI]: 387.8-815.6) to 403.0 (95% UI: 272.4-586.6), p < 0.001), age-adjusted DALYs per 100,000 population) but an uptrend of its inequalities (from 0.366 to 0.431, p < 0.001, Gini coefficients) was observed between 1990 and 2017. ID burden was heavier in women than that in men ([age-adjusted DALYs per 100,000 population from 742.2 to 514.3] vs [from 398.5 to 291.9]), but its inequalities were higher in men since 1990. The between-sex gap of ID burden was narrowed with higher HDI (β = - 364.11, p < 0.001). East Asia & Pacific and South Asia regions made a big stride for ID control in both sexes over decades [age-adjusted DALYs per 100,000 population from 378.7 (95% UI: 255.8-551.7) in 1990 to 138.9 (95%UI: 91.8-206.5) in 2017], while a heavy burden among Sub-Saharan African men was persistent[age-adjusted DALYs per 100,000 population, 572.5 (95% UI: 385.3-815) in 1990 and 562.6 (95% UI: 367.9-833.3) in 2017]. Conclusions: Redistributing attention and resources to help countries with low HDI, especially take care of women with low socioeconomic status (SES) and men under high ID burden may help hold back the expanding ID inequality.
Disease Burden of Inflammatory Bowel Disease in China from 1990 to 2019 and Its Predictions

Bule Shao,Wenjing Yang,Qian Cao

DOI: https://doi.org/10.2139/ssrn.4181716

2022-01-01

Abstract:Objective: China is one of the largest newly industrialized countries with the burden of inflammatory bowel disease (IBD) rising rapidly. Understanding the epidemiological trends and patterns of IBD in China is crucial for formulating effective strategies to tackle the disease.Methods: The prevalence, incidence, mortality, years of life lived with disability (YLDs), years of lost (YLLs), disability-adjusted life years (DALYs), and annual percentage changes of the above metrics of IBD in China from 1990 to 2019 were extracted from the Global Burden of Disease Study (GBD) 2019. The numbers and rates of incidence and mortality in the next 25 years were predicted.Results: From 1990 to 2019, the cases of IBD in China raised to 484 thousand [95% uncertainty interval (UI) 411-571] and 427 thousand (95% UI 366-498) among males and females, respectively. The age-standardised incidence rate of IBD increased from1.72 per 100,000 population (95% UI 1.44-2.05) to 3.35 per 100,000 population (95% UI 2.88-3.88) among males and from 1.20 per 100,000 population (95% UI 1.02-1.42) to 2.65 per 100,000 population (95% UI 2.29-3.08) among females. The highest incidence rate occurred in people aged 35-39 years. The total YLDs attributed to IBD significantly increased but the YLLs showed a decreasing trend, resulting in minor alterations of the DALYs. In the next 25 years, the incidence of IBD would continue to increase until a plateau and the number of deaths would also increase despite the decrease in the age-standardised mortality rate. Similar trends were observed for both sexes with a slight male predominance.Conclusion: Although China is still a low-endemic area of IBD, the prevalence and incidence of IBD dramatically increased in the past three decades and would continue to increase in the next 25 years. The substantial burden of IBD calls for collaboration between health policymakers, clinicians, and researchers.Funding: None.Declaration of Interest: The authors declare that they have no conflict of interest.Ethical Approval: The institutional review board of the Sir Run Run Shaw Hospital of Zhejiang University determined that the study did not need approval since the data used were publicly available.
Impact of iodine supply in infancy and childhood

Dominique Turck

DOI: https://doi.org/10.1097/mco.0000000000001036

2024-04-06

Current Opinion in Clinical Nutrition & Metabolic Care

Abstract:Purpose of review To assess the most relevant articles on the impact of iodine supply in at-risk populations, namely infants and young children, pregnant and lactating women. Recent findings The 2022 Iodine Global Network Annual Report confirmed the dramatic decrease of severe iodine deficiency over the last 30 years, thanks to universal iodine iodization. However, mild to moderate deficiency is still present in many countries, where recent data showed a decrease of iodine intake and an impairment of iodine status. Unfortunately, there is yet no validated biomarker to classify the iodine status at the individual level. Available data show that there is no clear evidence to link mild-to-moderate iodine deficiency to adverse health outcomes in pregnant and lactating women as well as in infants and children. The description of a negative impact of maternal iodine excess on neurodevelopment of infants is of concern. Summary Optimization of salt iodization (e.g. careful increase in iodine concentration in salt, use by food industry in processed foods) combined with targeted, personalized supplementation under medical supervision if needed (e.g. low intake of iodine rich foods, vegan diet) seems currently preferable to blanket supplementation.

endocrinology & metabolism,nutrition & dietetics
Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study

Juan Xin,Yiwen Luo,Wanwan Xiang,Sijing Zhu,Hui Niu,Jiayuan Feng,Landi Sun,Boxing Zhang,Xihui Zhou,Wenfang Yang

DOI: https://doi.org/10.3389/fpubh.2023.1282451

IF: 5.2

2024-01-10

Frontiers in Public Health

Abstract:Background: Neonatal disorders are facing serious public health challenges. Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories. Methods: Data were investigated from the Global Burden of Disease Study 2019. First, we visualized the burden of neonatal disorders using the number of cases and the age-standardized incidence rate (ASIR), death rate (ASDR), and disability-adjusted life years (ASR-DALYs) from 1990 to 2019. Second, estimated annual percentage changes (EAPCs) were used to evaluate the temporal trends of disease burden during different periods. Finally, the sociodemographic index (SDI) and human development index (HDI) were used to determine whether there exists a correlation between socioeconomic development level, human development level, and potential burden consequences. Results: Overall, in the past 30 years, the ASIR trends have remained relatively steady, whereas the ASDR and ASR-DALYs have declined. However, the burden of neonatal disorders varied greatly in various regions and countries. Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. Among 204 countries, the ASIR (EAPC = 3.35, 95%CI = 3.13–3.56) trend in Greece displayed the most significant increase, while the ASDR (EAPC = 1.26, 95%CI = 1.01–1.50) and ASR-DALYs (EAPC = 1.26, 95%CI = 1.03–1.49) trends in Dominica experienced the most substantial increase. Furthermore, there was a strong correlation between the EAPCs in ASIR, ASDR, ASR-DALYs, and SDI or HDI in 2019, with some exceptions. In addition, countries with elevated levels of HDI experienced a faster increase in ASDR and ASR-DALYs for neonatal disorders. Conclusion: Although the burden of neonatal disorders shows a downward trend from 1990 to 2019, it is still not optimistic. It is necessary to implement a multi-pronged approach to reduce the increasing burden of neonatal disorders.

public, environmental & occupational health
Iodine-induced thyroid dysfunction: a scientometric study and visualization analysis

Boshen Gong,Xichang Wang,Chuyuan Wang,Wanyu Yang,Zhongyan Shan,Yaxin Lai

DOI: https://doi.org/10.3389/fendo.2023.1239038

2023-09-20

Abstract:Objective: Iodine is essential in thyroid hormone production. Iodine deficiency is associated with serious complications (i.e miscarriage and stillbirth), whereas excess can cause thyroid dysfunction (i.e hyperthyroidism, hypothyroidism, thyroid autoimmunity). We conducted this scientometric study to visualize hot spots and trends in iodine-induced thyroid dysfunction over past two decades. The aim of this paper was to help scholars quickly understand the development and potential trend in this field, and guide future research directions. Methods: Articles on iodine-induced thyroid dysfunction from 2000 to 2022 were retrieved from the Web of Science Core Collection (WoSCC) using the following search terms: (((((TS=(hypothyroid*)) OR TS=(hyperthyroid*)) OR TS= ("TSH deficiency")) OR TS= ("thyroid stimulating hormone deficiency")) AND TS=(Iodine)) NOT TS=(radioiodine). Only publications in English were selected. CiteSpace, VOSviewer, Tableau, Carrot2, and R software were used to analyze the contribution and co-occurrence relationships of different countries, institutes, keywords, references, and journals. Results: A total of 2986 publications from 115 countries and 3412 research institutions were included. From 2000 to 2022, research on iodine-induced thyroid dysfunction progressed over a three-stage development period: initial development (2000-2009), stable development (2010-2016), and rapid development (2016-2022) period. The Journal of Clinical Endocrinology and Metabolism had the most co-citations followed and China Medical University (n=76) had the most publications. The top three clusters of co-citation references were isolated maternal hypothyroxinemia, subclinical hyperthyroidism, and brain development. Various scientific methods were applied to reveal acknowledge structure, development trend and research hotspots in iodine-induced thyroid dysfunction. Conclusion: Our scientometric analysis shows that investigations related to pregnant women, epidemiology surveys, and iodine deficiency are promising topics for future iodine-induced thyroid dysfunction research and highlights the important role of iodine on thyroid function.
Trends in three malnutrition factors in the global burden of disease: iodine deficiency, vitamin A deficiency, and protein-energy malnutrition (1990-2019)

Shaorong Ji,Yinglu Zhou,Qilong Zhao,Runtong Chen,Zhenni Su

DOI: https://doi.org/10.3389/fnut.2024.1426790

2024-07-23

Abstract:Background: Vitamin A deficiency, iodine deficiency, and protein-energy malnutrition are prevalent malnutrition issues that disproportionately affect low-income countries and pose significant risks to the health and development of children and adolescents. This study offers a detailed examination of these deficiencies' prevalence trends and gender and regional variations using Global Burden of Disease Study data from 1990 to 2019. It also assesses the specific impact on various age groups, providing essential insights for targeted health interventions and policy-making. Methods: Data spanning from 1990 to 2019 on Vitamin A deficiency, iodine deficiency, and protein-energy malnutrition were extracted from the 2019 Global Burden of Disease Study. Age-Standardized Incidence Rates (ASR) were computed by gender, region, and etiology, utilizing the estimated annual percentage change (EAPC) to assess temporal trends. Results: In 2019, Central Sub-Saharan Africa had the highest prevalence of Vitamin A deficiency, particularly among males, and iodine deficiency peaked in the same region for both genders. South Asia had the highest incidence of protein-energy malnutrition for both genders. Regions with a low Socio-Demographic Index (SDI) showed lower ASR for these deficiencies. Notably, Cameroon, Equatorial Guinea, and Maldives recorded the highest ASR for vitamin A deficiency, iodine deficiency, and protein-energy malnutrition, respectively. The declining ASR trend for vitamin A deficiency, especially among males, suggests effective interventions. East Asia saw a significant increase in iodine deficiency ASR from 1990 to 2019, particularly among women, requiring targeted interventions. The rising ASR of protein-energy malnutrition in several regions, especially among men, raises concerns. Vitamin A deficiency primarily affected children and adolescents, iodine deficiency predominantly impacted adolescents and young adults, and protein-energy malnutrition was chiefly observed among children under 5 years old. These findings underscore the necessity for tailored interventions considering age-specific nutritional needs and challenges.
The Characteristics of Iodine Nutrition Status in China After 20 Years of Universal Salt Iodization: An Epidemiology Study Covering 31 Provinces

Tingting Liu,Yongze Li,Di Teng,Xiaoguang Shi,Li Yan,Jing Yang,Yongli Yao,Zhen Ye,Jianming Ba,Bing Chen,Jianling Du,Lanjie He,Xiaoyang Lai,Xiaochun Teng,Yanbo Li,Haiyi Chi,Eryuan Liao,Chao Liu,Libin Liu,Guijun Qin,Yingfen Qin,Huibiao Quan,Bingyin Shi,Hui Sun,Xulei Tang,Nanwei Tong,Guixia Wang,Jin-an Zhang,Youmin Wang,Yuanming Xue,Lihui Yang,Qiao Zhang,Lihui Zhang,Jun Zhu,Mei Zhu,Zhongyan Shan,Weiping Teng

DOI: https://doi.org/10.1089/thy.2021.0301

IF: 6.506

2021-12-01

Thyroid

Abstract:Background: Despite the implementation of the universal salt iodization (USI) program for correction of iodine deficiency in China for ∼20 years, the actual iodine nutrition status of Chinese residents and the prevalence of iodine deficiency and iodine excess are issues that need to be addressed. This nationally representative cross-sectional study was conducted across all 31 provinces of mainland China to gather extensive data on iodine nutrition status and the influential factors. Methods: This study included 78,470 participants, aged 18 years or older, who were interviewed and asked to answer a questionnaire. Urine iodine concentration (UIC) was measured by the inductively coupled plasma mass spectrometry method, and goiter was examined by thyroid ultrasonography. In addition, sixty 9-11 years old school children in each province were randomly selected to evaluate the UIC and thyroid ultrasonography. The iodine nutrition status was determined according to the World Health Organization guidelines. Results: The iodized salt coverage was 95.37%. The median urine iodine (MUI) was 177.89 μg/L (interquartile range [IQR], 117.89-263.90 μg/L) and goiter prevalence was 1.17% (confidence interval [95% CI 0.95-1.43]) in the adult population. The MUI was 199.75 μg/L (IQR, 128.41-303.37 μg/L) in school-age children, and goiter prevalence was 3.50% [95% CI, 2.93-4.13]. The percentage of individuals with UIC <50 μg/L was 3.43%, <20%. Analysis indicated that sex, age, geographic factors, body mass index, and smoking habits influence the iodine nutrition level. Conclusion: The mandatory USI program has successfully eliminated iodine deficiency disorders, and the findings indicate that the iodine nutrition level in the general population is within the safe range.

endocrinology & metabolism
[Medical care of persons aged 25-84 years with acute myocardial infarction in Kaunas in 1996 (ischemic heart disease register data)].

I. Bluzhas,G. Bernotiene,R. Radišauskas,S. Domarkienė

Kardiologiia

Abstract:AIM To evaluate peculiarities of medical care provided for patients with acute myocardial infarction (AMI) depending on sex and age in Kaunas in 1996. METHODS Kaunas community-based ischemic heart disease register conducted according to the WHO MONICA Project methodology was the source of the data. RESULTS Number of diagnosed acute myocardial infarctions among Kaunas population aged 25-84 years in 1996 was 1269. Only 28 day AMI survivors were considered in the present study (n=626). During first 4 hours from onset of chest pain male patients sought for medical assistance as frequently as female AMI patients: 38.1% and 34.0%, respectively. A mobile team provided first medical aid in 62.3% of cases. Thrombolytics were used in each 11th men and in 3% of women. Percutaneous coronary angioplasty was carried out in 4.9 and 1.2% of men and women, respectively. Coronary angiography and angioplasty were more often performed in men (13.1 and 4.9%, respectively) than in women (2.7 and 1.2, respectively).
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019

Zhili Dou,Huiling Zheng,Yanyan Shi,Yuan Li,Jinzhu Jia

DOI: https://doi.org/10.1016/j.autrev.2024.103655

2024-10-02

Abstract:Background: Inflammatory bowel disease (IBD) is a kind of chronic inflammatory disorders of the gastrointestinal tract with diverse prevalence rates and patterns globally. Accurate comprehension of the disease's epidemiological characteristics is imperative for disease control and prevention all over the world. Objective: To provide the most updated estimates on the global burden of IBD using the 2019 Global Burden of Disease (GBD) study data, to systematically analyze the IBD epidemiological characteristics at the global, regional, and national levels including the prevalence, incidence, and disability-adjusted life years (DALY) rates, and to analyze the correlations of the socioeconomic development level with IBD epidemiological characteristics. Methods: We conducted an overall analysis of the global, regional, and national burden of IBD from 1990 to 2019, data from the 2019 GBD study. The GBD's classification of the world into 21 regions and 204 countries and territories facilitated a thorough examination. Age-standardized estimated annual percentage changes (EAPCs) were computed to assess the temporal trends in IBD age-standardized rates (ASRs), with age standardization employed to mitigate potential confounding effects from age structure. The sociodemographic Index (SDI) was used to correlate the socioeconomic development level with the epidemiological characteristics of IBD. Results: From 1990 to 2019, the global age-standardized prevalence, incidence, and DALY rates of IBD remained high. There was a slight downward trend in the global age-standardized incidence and DALY rates of IBD and men exhibited higher DALY rates than women. In 2019, high-income North America recorded the highest age-standardized prevalence, incidence, and DALY rates, while Oceania had the lowest age-standardized prevalence and incidence rates. South Asia had the lowest age-standardized DALY rates. The age-standardized mortality and DALY rates decreased as SDI values increased and remained higher than the expected levels over the past three decades. A negative correlation was observed between age-standardized DALY rates and SDI at the national level. Conclusions: This analysis of the GBD 2019 database demonstrates that the overall global burden of IBD is still high. Meanwhile, an increasing disease burden is observed in the middle and low SDI locations.
Mammaglobin as a Marker for the Detection of Tumor Cells in the Peripheral Blood of Breast Cancer Patients

O. Zach,H. Kasparu,H. Wagner,O. Krieger,D. Lutz

DOI: https://doi.org/10.1111/j.1749-6632.2000.tb05547.x

IF: 6.499

2000-12-01

Annals of the New York Academy of Sciences

Abstract:The detection of circulating tumor cells in the peripheral blood (pB) of breast cancer (BC) patients might become an important factor for the prognosis of BC patients. Sensitive molecular techniques, primarily based upon the reverse-transcriptase polymerase chain reaction (RT-PCR), have been developed using the expression of tissueand/or tumor-specific genes as a marker for the presence of tumor cells. In 1996, the cDNA of a novel gene termed human mammaglobin (hMAM) was described.1 As far as known, the expression of hMAM is restricted to the adult mammary gland and to breast carcinoma cells; therefore, it might be a specific marker for BC cells. We developed a nested RT-PCR assay for the detection of hMAM mRNA molecules in the pB of BC patients as a marker for the presence of tumor cells.2 The assay is highly sensitive (1 tumor cell detectable in 106–107 white blood cells) and specific for breast carcinoma cells (no hMAM expression in pB of healthy volunteers). Peripheral blood samples from 286 BC patients (27–94 years, mean of 58 years) were classified into four defined clinical subgroups: before (pre) and after (post) surgery (without metastases and before any further adjuvant treatment), no evidence of disease (NED, stages I–III or relapsed, and after chemotherapy-induced remission), and metastatic disease (MD, stage IV and relapses of earlier stages). RNA was isolated out of 2× 5 mL pB per sample and patient, cDNA was synthesized, and nested PCR was performed with two PCR setups per cDNA, resulting in four PCR setups per sample.2 In all assays, freshly prepared cDNAs from dilutions of 10 cells of the mammary carcinoma cell line SKBR5 in 5 mL pB and from pB of healthy volunteers were used as positive and negative controls, respectively. Results of pB samples from BC patients tested for hMAM mRNA expression via a nested RT-PCR assay were as follows: 2/46 (4%) pre, 2/24 (8%) post, 4/135 (3%) NED, and 35/81 (43%) MD (TABLE 1). Significantly more MD patients were hMAM-positive than patients of the other subgroups (p < 0.0001). The detection of tumor cells in pB of BC patients is limited to tumors that do express hMAM. It has been shown that about 80% of mammary carcinomas are strongly immunopositive for hMAM protein.3 In addition, cells derived from breast

T-lymphocytes in B-cell chronic lymphocytic leukaemia.

The burden of iodine deficiency

Changing trends in the global, regional, and national burden of iodine deficiency among adolescents and young adults: population-based study

Burden and trends of iodine deficiency in Asia from 1990 to 2019

Cross-country health inequalities of four common nutritional deficiencies among children, 1990 to 2019: data from the Global Burden of Disease Study 2019

Iron Deficiency: Global Trends and Projections from 1990 to 2050

WITHDRAWN: Cardio-cerebrovascular protective effects of valsartan in high-risk hypertensive patients with overweight/obesity: A post-hoc analysis of the KYOTO HEART Study.

[Trends of the Disease Burden of Intellectual Disability among Children and Adolescents from 1990 to 2019 in China].

Global Patterns in Vision Loss Burden Due to Vitamin A Deficiency from 1990 to 2017.

Iodine Deficiency in Zhejiang Pregnant Women in the Context of Universal Salt Iodization Programme

Global, regional, and national burdens of nutritional deficiencies, from 1990 to 2019

Global burden and inequality of iron deficiency: findings from the Global Burden of Disease datasets 1990-2017

Disease Burden of Inflammatory Bowel Disease in China from 1990 to 2019 and Its Predictions

Impact of iodine supply in infancy and childhood

Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study

Iodine-induced thyroid dysfunction: a scientometric study and visualization analysis

Trends in three malnutrition factors in the global burden of disease: iodine deficiency, vitamin A deficiency, and protein-energy malnutrition (1990-2019)

The Characteristics of Iodine Nutrition Status in China After 20 Years of Universal Salt Iodization: An Epidemiology Study Covering 31 Provinces

[Medical care of persons aged 25-84 years with acute myocardial infarction in Kaunas in 1996 (ischemic heart disease register data)].

Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019

Mammaglobin as a Marker for the Detection of Tumor Cells in the Peripheral Blood of Breast Cancer Patients